CD4计数<200细胞·μL−1 |
|
|
|
|
|
Chest radiograph |
41 |
100 (81–100) |
42(22–63) |
55(36–73) |
100 (69–100) |
Chest radiograph in smear-negative patients |
34 |
100 (69–100) |
42(22–63) |
42(22–63) |
100 (69–100) |
QFT-GIT |
40 |
76(53–92) |
84 (60–97) |
84 (60–97) |
76(53–92) |
QFT-GIT in smear-negative patients |
30 |
82 (48–98) |
84 (60–97) |
75 (43–95) |
89(65–99) |
T-SPOT®.TB |
48 |
90(67–99) |
69 (49–85) |
65 (44–83) |
91(71–99) |
T-SPOT®.TBin smear-negative patients |
39 |
80 (44–98) |
69 (49–85) |
47(23-72) |
91(71–99) |
CD4 count ≥200 cells·μL−1 |
|
|
|
|
|
Chest radiograph |
35 |
100(75–100) |
18 (5–40) |
42 (25–61) |
100 (40–100) |
Chest radiograph in smear-negative patients |
27 |
100 (48–100) |
18 (5–40) |
22 (8–44) |
100 (40–100) |
QFT-GIT |
43 |
61(36-83) |
40(21–61) |
42(23-63) |
59 (33–82) |
QFT-GIT in smear-negative patients |
30 |
60(15–95) |
40(21–61) |
17(4-41) |
83(52–98) |
T-SPOT®.TB |
44 |
78 (52–94) |
65 (44–83) |
61 (39–80) |
81 (58–95) |
T-SPOT®.TBin smear-negative patients |
30 |
50 (7–93) |
65 (44–83) |
18 (2–52) |
90(67–99) |